99 related articles for article (PubMed ID: 10417427)
1. [Nonsurgical treatment of hepatocellular carcinoma].
Raoul JL; Boucher E; Kerbrat P
Bull Cancer; 1999 Jun; 86(6):537-43. PubMed ID: 10417427
[TBL] [Abstract][Full Text] [Related]
2. Nonresectional therapies for hepatocellular carcinoma.
Liu CL; Fan ST
Am J Surg; 1997 Apr; 173(4):358-65. PubMed ID: 9136797
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hepatocellular carcinoma: medical options.
Fried MW
Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S92-7. PubMed ID: 9742500
[TBL] [Abstract][Full Text] [Related]
4. [Nonsurgical therapy of focal liver lesions].
Allgaier HP; Deibert P; Blum HE
Praxis (Bern 1994); 1997 Jan; 86(4):86-90. PubMed ID: 9064724
[TBL] [Abstract][Full Text] [Related]
5. Survival of cirrhotic patients with early hepatocellular carcinoma treated by percutaneous ethanol injection or liver transplantation.
Andriulli A; de Sio I; Solmi L; De Carlis L; Troisi R; Grasso A; Festa V; Caturelli E; Giacomoni A; Del Vecchio Blanco C; De Hemptinne B; Burroughs A; Perri F
Liver Transpl; 2004 Nov; 10(11):1355-63. PubMed ID: 15497162
[TBL] [Abstract][Full Text] [Related]
6. Nonsurgical treatment of hepatocellular carcinoma.
Llovet JM; Sala M; Bruix J
Liver Transpl; 2000 Nov; 6(6 Suppl 2):S11-5. PubMed ID: 11084079
[TBL] [Abstract][Full Text] [Related]
7. [Different strategies for treatment of hepatocellular carcinoma in the west and in the east].
Makuuchi M; Kita Y; Takayama T
Gan To Kagaku Ryoho; 1998 Jul; 25(8):1137-43. PubMed ID: 9679575
[TBL] [Abstract][Full Text] [Related]
8. Local/regional and systemic treatments of hepatocellular carcinoma.
Beaugrand M; N'kontchou G; Seror O; Ganne N; Trinchet JC
Semin Liver Dis; 2005; 25(2):201-11. PubMed ID: 15918148
[TBL] [Abstract][Full Text] [Related]
9. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center.
Ueno S; Tanabe G; Nuruki K; Oketani M; Komorizono Y; Hokotate H; Fukukura Y; Baba Y; Imamura Y; Aikou T
J Hepatobiliary Pancreat Surg; 2002; 9(4):469-77. PubMed ID: 12483269
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma (HCC): an update.
Rougier P; Mitry E; Barbare JC; Taieb J
Semin Oncol; 2007 Apr; 34(2 Suppl 1):S12-20. PubMed ID: 17449346
[TBL] [Abstract][Full Text] [Related]
12. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma].
Wu DH; Chen LH
Ai Zheng; 2004 Jul; 23(7):825-8. PubMed ID: 15248921
[TBL] [Abstract][Full Text] [Related]
14. [Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
Chen XM; Luo PF; Lin HH; Zhou ZJ; Shao PJ; Fu L; Li WK
Ai Zheng; 2004 Jul; 23(7):829-32. PubMed ID: 15248922
[TBL] [Abstract][Full Text] [Related]
15. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
Marotta F; Vangieri B; Cecere A; Gattoni A
Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.
Pompili M; Mirante VG; Rondinara G; Fassati LR; Piscaglia F; Agnes S; Covino M; Ravaioli M; Fagiuoli S; Gasbarrini G; Rapaccini GL
Liver Transpl; 2005 Sep; 11(9):1117-26. PubMed ID: 16123960
[TBL] [Abstract][Full Text] [Related]
17. Treatment and prognosis of hepatocellular carcinoma: a population based study in France.
Borie F; Bouvier AM; Herrero A; Faivre J; Launoy G; Delafosse P; Velten M; Buemi A; Peng J; Grosclaude P; Trétarre B
J Surg Oncol; 2008 Dec; 98(7):505-9. PubMed ID: 18932235
[TBL] [Abstract][Full Text] [Related]
18. [Hepatocellular carcinoma. Pathogenesis and multicentricity].
Blum HE; Hopt UT
Chirurg; 2003 Aug; 74(8):709-16. PubMed ID: 12928791
[TBL] [Abstract][Full Text] [Related]
19. Multimodality management of hepatocellular carcinoma larger than 10 cm.
Mok KT; Wang BW; Lo GH; Liang HL; Liu SI; Chou NH; Tsai CC; Chen IS; Yeh MH; Chen YC
J Am Coll Surg; 2003 Nov; 197(5):730-8. PubMed ID: 14585406
[TBL] [Abstract][Full Text] [Related]
20. [Hepatocellular carcinoma: percutaneous ethanol injection/transarterial chemoembolization/radiofrequency thermoablation].
Allgaier HP; Rossi S; Deibert P; Zuber I; Hering M; Blum HE
Praxis (Bern 1994); 2000 Jun; 89(24):1056-60. PubMed ID: 10902462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
